NiQuitin 2 mg Lozenges

দেশ: যুক্তরাজ্য

ভাষা: ইংরেজি

সূত্র: myHealthbox

সক্রিয় উপাদান:

nicotine

থেকে পাওয়া:

Omega Pharma Ltd

এটিসি কোড:

N07BA01

INN (আন্তর্জাতিক নাম):

nicotine

ডোজ:

2 mg

ফার্মাসিউটিকাল ফর্ম:

Lozenge

প্রশাসন রুট:

oral use

প্যাকেজ ইউনিট:

packs of 12, 36, 72, 96, 108 and 144

প্রেসক্রিপশন টাইপ:

GSL - General Sales List

Manufactured by:

Famar A.VE. Avlon

থেরাপিউটিক ইঙ্গিত:

NiQuitin Lozenges relieve and/or prevent craving and nicotine withdrawal symptoms associated with tobacco dependence. They are indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. NiQuitin Lozenges are indicated in pregnant and lactating women making a quit attempt. NiQuitin Lozenges should preferably be used in conjunction with a behavioral support programme.

অনুমোদন অবস্থা:

Authorised

অনুমোদন তারিখ:

2015-12-24

পণ্য বৈশিষ্ট্য

1L4XLWLQPJ/R]HQJHV
6XPPDU\RI3URGXFW&KDUDFWHULVWLFV8SGDWHG$SU_2PHJD3KDUPD/WG
1DPHRIWKHPHGLFLQDOSURGXFW
1L4XLWLQPJ/R]HQJHV
4XDOLWDWLYHDQGTXDQWLWDWLYHFRPSRVLWLRQ
(DFKOR]HQJHFRQWDLQVPJQLFRWLQHDVQLFRWLQHUHVLQDWH)RUH[FLSLHQWVVHH6HFWLRQ
3KDUPDFHXWLFDOIRUP
/R]HQJH
:KLWHURXQGOR]HQJHZLWKFRQYH[VXUIDFHVGHERVVHG1/RQRQHVLGH
&OLQLFDOSDUWLFXODUV
7KHUDSHXWLFLQGLFDWLRQV
1L4XLWLQ/R]HQJHVUHOLHYHDQGRUSUHYHQWFUDYLQJDQGQLFRWLQHZLWKGUDZDOV\PSWRPVDVVRFLDWHGZLWKWREDFFR
GHSHQGHQFH7KH\DUHLQGLFDWHGWRDLGVPRNHUVZLVKLQJWRTXLWRUUHGXFHSULRUWRTXLWWLQJWRDVVLVWVPRNHUVZKRDUH
XQZLOOLQJRUXQDEOHWRVPRNHDQGDVDVDIHUDOWHUQDWLYHWRVPRNLQJIRUVPRNHUVDQGWKRVHDURXQGWKHP
1L4XLWLQ/R]HQJHVDUHLQGLFDWHGLQSUHJQDQWDQGODFWDWLQJZRPHQPDNLQJDTXLWDWWHPSW
1L4XLWLQ/R]HQJHVVKRXOGSUHIHUDEO\EHXVHGLQFRQMXQFWLRQZLWKDEHKDYLRUDOVXSSRUWSURJUDPPH
3RVRORJ\DQGPHWKRGRIDGPLQLVWUDWLRQ
_'LUHFWLRQVIRUXVH_
1L4XLWLQPJ/R]HQJHVDUHVXLWDEOHIRUVPRNHUVZKRKDYHWKHLUILUVWFLJDUHWWHRIWKHGD\PRUHWKDQPLQXWHVDIWHU
ZDNLQJXS
2QHOR]HQJHVKRXOGEHSODFHGLQWKHPRXWKDQGDOORZHGWRGLVVROYH3HULRGLFDOO\WKHOR]HQJHVKRXOGEHPRYHGIURP
RQHVLGHRIWKHPRXWKWRWKHRWKHUDQGUHSHDWHGXQWLOWKHOR]HQJHLVFRPSOHWHO\GLVVROYHGDSSUR[LPDWHO\±
PLQXWHV7KHOR]HQJHVKRXOGQRWEHFKHZHGRUVZDOORZHGZKROH
8VHUVVKRXOGQRWHDWRUGULQNZKLOHDOR]HQJHLVLQWKHPRXWK
%HKDYLRXUDOWKHUDS\DGYLFHDQGVXSSRUWZLOOQRUPDOO\LPSURYHWKHVXFFHVVUDWH
$GXOWV\HDUVDQGRYHU
_$EUXSWFHVVDWLRQRIVPRNLQJ_
8VHUVVKRXOGPDNHHYHU\HIIRUWWRVWRSVPRNLQJFRPSOHWHO\GXULQJWUHDWPHQWZLWK1L4XLWLQ/R]HQJHV
5HFRPPHQGHGWUHDWPHQWVFKHGXOH
6WHS:HHNVWR
6WHS:HHNVWR
6WHS:HHNVWR
,QLWLDOWUHDWPHQWSHULRG
6WHSGRZQWUHDWPHQWSHULRG
6WHSGRZQWUHDWPHQWSHULRG
OR]HQJHHYHU\WRKRXUV
OR]HQJHHYHU\WRKRXUV
OR]HQJHHYHU\WRKRXUV
'XULQJZHHNVWRLWLVUHFRPPHQGHGWKDWXVHUVWDN